Pro-Dex Q4 revenue beats estimates on orthopedic handpiece sales
PDEX•Outlook not provided
The company did not provide specific guidance for the upcoming quarter or fiscal year.
What drove the results
- Next generation handpiece: The company said higher Q4 sales were driven by increased shipments of its largest customer's next generation orthopedic handpiece.
- Favorable product mix and APM contribution: Gross margin improvement was attributed to favorable product mix, better absorption of indirect manufacturing costs, and margins from subsidiary APM.
- Higher operating expenses: Q4 operating expenses rose due to personnel costs, APM administrative expenses, consulting payments, and allowance for uncollectible receivables.
Key figures and valuation notes
| Metric | Actual | Consensus |
|---|---|---|
| Q4 Revenue | $20.41 million | $19.20 million |
| Q4 EPS | $0.87 | N/A |
| Q4 Net Income | $2.86 million | N/A |
| Q4 Gross Profit | $7.09 million | N/A |
| Q4 Operating Expenses | $3.56 million |
